Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 36.34 Million USD | 23.81% |
| 2022 | 29.36 Million USD | -26.8% |
| 2021 | 40.1 Million USD | 1.66% |
| 2020 | 39.45 Million USD | 73.3% |
| 2019 | 22.76 Million USD | 12.41% |
| 2018 | 20.25 Million USD | 51.34% |
| 2017 | 13.38 Million USD | 63.07% |
| 2016 | 8.2 Million USD | 102.33% |
| 2015 | 4.05 Million USD | 28.96% |
| 2014 | 3.14 Million USD | 282.7% |
| 2013 | 821.78 Thousand USD | 442.17% |
| 2012 | 151.57 Thousand USD | 320.13% |
| 2011 | 36.07 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 10 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.78 Million USD | 12.9% |
| 2024 Q2 | 9.89 Million USD | 1.11% |
| 2023 Q4 | 8.66 Million USD | 11.79% |
| 2023 Q2 | 8.07 Million USD | 2.05% |
| 2023 Q1 | 7.91 Million USD | 3.51% |
| 2023 Q3 | 7.75 Million USD | -3.94% |
| 2023 FY | 36.34 Million USD | 23.81% |
| 2022 Q3 | 6.46 Million USD | -11.84% |
| 2022 Q4 | 7.64 Million USD | 18.25% |
| 2022 Q2 | 7.33 Million USD | -7.49% |
| 2022 FY | 29.36 Million USD | -26.8% |
| 2022 Q1 | 7.92 Million USD | -18.29% |
| 2021 Q4 | 9.69 Million USD | 8.94% |
| 2021 FY | 40.1 Million USD | 1.66% |
| 2021 Q1 | 10.14 Million USD | -12.03% |
| 2021 Q2 | 11.36 Million USD | 12.05% |
| 2021 Q3 | 8.9 Million USD | -21.68% |
| 2020 Q1 | 8.15 Million USD | 23.38% |
| 2020 Q2 | 9.52 Million USD | 16.73% |
| 2020 Q4 | 11.53 Million USD | 12.54% |
| 2020 Q3 | 10.24 Million USD | 7.62% |
| 2020 FY | 39.45 Million USD | 73.3% |
| 2019 Q1 | 4.57 Million USD | -16.35% |
| 2019 FY | 22.76 Million USD | 12.41% |
| 2019 Q2 | 5.85 Million USD | 27.83% |
| 2019 Q3 | 5.72 Million USD | -2.09% |
| 2019 Q4 | 6.61 Million USD | 15.4% |
| 2018 Q1 | 4.43 Million USD | 3.19% |
| 2018 Q2 | 5.24 Million USD | 18.32% |
| 2018 FY | 20.25 Million USD | 51.34% |
| 2018 Q3 | 5.1 Million USD | -2.72% |
| 2018 Q4 | 5.47 Million USD | 7.21% |
| 2017 Q3 | 3.44 Million USD | 13.41% |
| 2017 FY | 13.38 Million USD | 63.07% |
| 2017 Q1 | 2.59 Million USD | -0.64% |
| 2017 Q2 | 3.04 Million USD | 17.14% |
| 2017 Q4 | 4.29 Million USD | 24.57% |
| 2016 Q2 | 1.85 Million USD | 15.98% |
| 2016 Q1 | 1.59 Million USD | 6.81% |
| 2016 FY | 8.2 Million USD | 102.33% |
| 2016 Q4 | 2.61 Million USD | 21.92% |
| 2016 Q3 | 2.14 Million USD | 15.68% |
| 2015 Q4 | 1.49 Million USD | 39.58% |
| 2015 FY | 4.05 Million USD | 28.96% |
| 2015 Q3 | 1.07 Million USD | 36.62% |
| 2015 Q2 | 784.28 Thousand USD | 11.33% |
| 2015 Q1 | 704.49 Thousand USD | -19.36% |
| 2014 Q3 | 1.03 Million USD | 55.36% |
| 2014 Q2 | 665.73 Thousand USD | 16.61% |
| 2014 Q1 | 570.91 Thousand USD | 81.73% |
| 2014 FY | 3.14 Million USD | 282.7% |
| 2014 Q4 | 873.65 Thousand USD | -15.53% |
| 2013 Q4 | 314.15 Thousand USD | 54.33% |
| 2013 Q1 | 176.09 Thousand USD | 130.0% |
| 2013 Q2 | 127.96 Thousand USD | -27.33% |
| 2013 Q3 | 203.56 Thousand USD | 59.07% |
| 2013 FY | 821.78 Thousand USD | 442.17% |
| 2012 FY | 151.57 Thousand USD | 320.13% |
| 2012 Q1 | 16.89 Thousand USD | -53.18% |
| 2012 Q3 | 605.34 Thousand USD | 1732.05% |
| 2012 Q2 | 33.04 Thousand USD | 95.6% |
| 2012 Q4 | -587.04 Thousand USD | -196.98% |
| 2011 Q4 | 36.07 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | 36.07 Thousand USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 100.0% |
| 2006 Q4 | -4145.00 USD | 0.0% |
| 2006 Q1 | 4145.00 USD | -21.24% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | -100.0% |
| 2005 FY | 10 Thousand USD | 0.0% |
| 2005 Q4 | 5263.00 USD | 25.82% |
| 2005 Q3 | 4183.00 USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -201.429% |
| BrainsWay Ltd. | 31.78 Million USD | -14.36% |
| Cerus Corporation | 156.36 Million USD | 76.754% |
| Envoy Medical, Inc. | 316 Thousand USD | -11402.968% |
| electroCore, Inc. | 16.03 Million USD | -126.758% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -5544.314% |
| IceCure Medical Ltd | 3.22 Million USD | -1025.716% |
| Inogen, Inc. | 315.66 Million USD | 88.485% |
| OrthoPediatrics Corp. | 148.73 Million USD | 75.56% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -1397.091% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -9858.761% |
| MaxCyte, Inc. | 41.28 Million USD | 11.961% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -1761.74% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -32721.702% |
| Orthofix Medical Inc. | 746.64 Million USD | 95.132% |
| PAVmed Inc | 2.45 Million USD | -1382.438% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -61.416% |
| RxSight, Inc. | 89.07 Million USD | 59.193% |
| Sight Sciences, Inc. | 81.05 Million USD | 55.155% |
| SI-BONE, Inc. | 138.88 Million USD | 73.828% |
| TELA Bio, Inc. | 58.45 Million USD | 37.814% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 80.574% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -163.382% |
| Acutus Medical, Inc. | 7.16 Million USD | -407.389% |
| Talis Biomedical Corporation | 412 Thousand USD | -8722.665% |
| Spectral AI, Inc. | 18.05 Million USD | -101.315% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -266.98% |
| CVRx, Inc. | 39.29 Million USD | 7.496% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -3652.364% |
| Bioventus Inc. | 512.34 Million USD | 92.905% |
| Venus Concept Inc. | 76.35 Million USD | 52.394% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -96.366% |
| LivaNova PLC | 1.15 Billion USD | 96.849% |
| 908 Devices Inc. | 50.22 Million USD | 27.633% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 92.463% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -47080.026% |
| NeuroPace, Inc. | 65.42 Million USD | 44.438% |
| LENSAR, Inc. | 42.16 Million USD | 13.79% |
| Apyx Medical Corporation | 52.34 Million USD | 30.563% |
| Cutera, Inc. | 212.36 Million USD | 82.884% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -8.968% |
| BioSig Technologies, Inc. | 18 Thousand USD | -201840.994% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 78.19% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -51.74% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 97.642% |
| Axonics, Inc. | 366.37 Million USD | 90.079% |
| Outset Medical, Inc. | 130.37 Million USD | 72.12% |
| IRIDEX Corporation | 51.86 Million USD | 29.921% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 73.31% |
| IRadimed Corporation | 65.56 Million USD | 44.557% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -2990.934% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1103.393% |
| Telesis Bio, Inc. | 27.5 Million USD | -32.136% |
| Viemed Healthcare, Inc. | 183 Million USD | 80.138% |
| Varex Imaging Corporation | 811 Million USD | 95.518% |
| Quipt Home Medical Corp. | 221.74 Million USD | 83.607% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 47.07% |
| Dynatronics Corporation | 32.53 Million USD | -11.727% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -318.868% |
| Semler Scientific, Inc. | 68.18 Million USD | 46.689% |
| InMode Ltd. | 492.04 Million USD | 92.613% |
| Bruker Corporation | 2.96 Billion USD | 98.774% |
| DexCom, Inc. | 3.62 Billion USD | 98.997% |
| Align Technology, Inc. | 3.86 Billion USD | 99.059% |
| Viveve Medical, Inc. | 6.42 Million USD | -465.661% |
| ZimVie Inc. | 457.43 Million USD | 92.054% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 81.168% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -32721.702% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 95.139% |
| Profound Medical Corp. | 7.33 Million USD | -395.83% |
| Insulet Corporation | 1.69 Billion USD | 97.858% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 71.169% |
| iCAD, Inc. | 17.31 Million USD | -109.894% |
| Nuwellis, Inc. | 8.86 Million USD | -310.079% |
| Biotricity, Inc. | 12.06 Million USD | -201.321% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 92.622% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -485.808% |
| PAVmed Inc. | 2.45 Million USD | -1382.438% |
| BIOLASE, Inc. | 49.16 Million USD | 26.065% |
| Beyond Air, Inc. | 1.15 Million USD | -3036.271% |
| FONAR Corporation | 102.88 Million USD | 64.67% |
| AxoGen, Inc. | 159.01 Million USD | 77.14% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 86.754% |
| Inari Medical, Inc. | 493.63 Million USD | 92.636% |
| UFP Technologies, Inc. | 400.07 Million USD | 90.914% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -195326.769% |
| Tenon Medical, Inc. | 2.92 Million USD | -1141.441% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -433.605% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.864% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1283.684% |
| NanoVibronix, Inc. | 2.28 Million USD | -1492.176% |
| Quanterix Corporation | 122.36 Million USD | 70.295% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -48.942% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 81.873% |
| TransMedics Group, Inc. | 241.62 Million USD | 84.956% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -162.375% |
| NeuroMetrix, Inc. | 5.9 Million USD | -515.942% |
| Hyperfine, Inc. | 11.03 Million USD | -229.49% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 77.99% |
| Biomerica, Inc. | 5.41 Million USD | -571.272% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 28.108% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 79.479% |